| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 24 |
| 1 | GABAPENTIN | 24 |
| 2 | LEVOTHYROXINE SODIUM | 20 |
| 3 | ADALIMUMAB | 18 |
| 4 | METHOTREXATE SODIUM | 18 |
| 5 | METHOTREXATE | 17 |
| 6 | OMEPRAZOLE MAGNESIUM | 17 |
| 7 | PREDNISONE | 16 |
| 8 | ALPRAZOLAM | 15 |
| 9 | PANTOPRAZOLE | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NONOXYNOL-9 | 1 | 0.0714 |
| 1 | FERRIC SUBSULFATE | 1 | 0.0385 |
| 2 | PHENAZOPYRIDINE HYDROCHLORIDE | 3 | 0.0091 |
| 3 | METHAZOLAMIDE | 1 | 0.0029 |
| 4 | PENCICLOVIR | 1 | 0.0028 |
| 5 | WHITE PETROLATUM | 4 | 0.0028 |
| 6 | GLUTATHIONE | 4 | 0.0023 |
| 7 | EPINEPHRINE INHALATION | 1 | 0.0020 |
| 8 | LEVOLEUCOVORIN INJECTION | 6 | 0.0020 |
| 9 | PLATINUM | 1 | 0.0019 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 48 |
| 1 | Corticosteroid [EPC] | 39 |
| 2 | Benzodiazepine [EPC] | 36 |
| 3 | Estrogen [EPC] | 23 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 23 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 22 |
| 6 | Vitamin C [EPC] | 21 |
| 7 | Proton Pump Inhibitor [EPC] | 19 |
| 8 | Factor Xa Inhibitor [EPC] | 17 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 17 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |
| 1 | Plasma Volume Expander [EPC] | 2 | 0.0006 |
| 2 | Provitamin D2 Compound [EPC] | 15 | 0.0005 |
| 3 | Phosphodiesterase 3 Inhibitor [EPC] | 3 | 0.0005 |
| 4 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 5 | Anthelmintic [EPC] | 1 | 0.0003 |
| 6 | Human C1 Esterase Inhibitor [EPC] | 1 | 0.0003 |
| 7 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 8 | Sympathomimetic-like Agent [EPC] | 7 | 0.0002 |
| 9 | Bismuth [EPC] | 1 | 0.0002 |